aTyr Pharma (LIFE) Insider Trading & Ownership → Elon Musk’s Controversial New Project: “Apollo” (From InvestorPlace) (Ad) Free LIFE Stock Alerts $1.62 -0.02 (-1.22%) (As of 04/23/2024 ET) Add Compare Share Share Insider TradesStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial Media aTyr Pharma (NASDAQ:LIFE) Insider Buying and Selling ActivityCurrentInsider OwnershipPercentage3.70%Number OfInsiders Buying(Last 12 Months)2Amount OfInsider Buying(Last 12 Months)$453,510.00Number OfInsiders Selling(Last 12 Months)0 Get LIFE Insider Trade Alerts Want to know when executives and insiders are buying or selling aTyr Pharma stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address LIFE Insider Buying and Selling by Quarter Ad Wall Street StarThis Apple-like Innovator is Revolutionizing HealthcareAI has infiltrated so many sectors, it's sent the demand for AI-friendly GPU computer chips rocketing. Nvidia has gone up more than 3x in the past year. It is now valued well over $2 trillion, making it one of the largest companies in the world.Click here to learn more about the booming eHealth industry aTyr Pharma Insider and Congressional Trades History Insiders and Members of Congress Insiders Only Members of Congress Only Transaction Type Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years Time Frame * Start Date * End Date Export to Excel Transaction DateNameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails12/11/2023Sanjay ShuklaCEOBuy3,000$1.17$3,510.00 5/10/2023Paul SchimmelDirectorBuy200,000$2.25$450,000.00 (Data available from 1/1/2013 forward) LIFE Insider Trading Activity - Frequently Asked Questions Who is on aTyr Pharma's Insider Roster? The list of insiders at aTyr Pharma includes Jill Marie Broadfoot, John K Clarke, Paul Schimmel, and Sanjay Shukla. Learn more on insiders at LIFE. What percentage of aTyr Pharma stock is owned by insiders? 3.70% of aTyr Pharma stock is owned by insiders. Learn more on LIFE's insider holdings. Which aTyr Pharma insiders have been buying company stock? The following insiders have purchased LIFE shares in the last 24 months: Paul Schimmel ($450,000.00), and Sanjay Shukla ($68,110.00). How much insider buying is happening at aTyr Pharma? Insiders have purchased a total of 228,000 LIFE shares in the last 24 months for a total of $518,110.00 bought. Which aTyr Pharma insiders have been selling company stock? The following insider sold LIFE shares in the last 24 months: Jill Marie Broadfoot ($3,695.76). How much insider selling is happening at aTyr Pharma? Insiders have sold a total of 1,566 aTyr Pharma shares in the last 24 months for a total of $3,695.76 sold. More Insider Trading Tools from MarketBeat Related Companies: BLUE Insider Ownership VIGL Insider Ownership OTLK Insider Ownership SGMO Insider Ownership BCAB Insider Ownership CRIS Insider Ownership DTIL Insider Ownership ZURA Insider Ownership AGEN Insider Ownership OMGA Insider Ownership Insider Tracking Tools: CEO Purchases/Sales CFO Purchases/Sales Top Insider Buying Stocks Top Insider Selling Stocks Insider Trades Screener Insider Trades Newsletter Congressional Stock Trades Insider Trading By Country: U.S. Insider Trading Activity Canadian Insider Trading Activity U.K. Insider Trading Activity Australia Insider Trading Activity Latest Articles: The 5 Stocks Most Sold By Insiders This Year3 Cheap Stocks Insiders are Buying: Investors Should Avoid 1The 5 Hottest CEO Stock Purchases So Far This Year3 Cheap Stocks that Insiders Bought in Q1Michael Burry Picked a Winner With GEN Restaurant Group This page (NASDAQ:LIFE) was last updated on 4/24/2024 by MarketBeat.com Staff From Our PartnersThis Apple-like Innovator is Revolutionizing HealthcareWall Street Startop AI stock (it’s not MSFT, GOOGL, AMZN or AAPL)Traders AgencySHOCKING Crypto Leak…Crypto 101 MediaThe #1 Crypto for 2024InvestorPlaceDon’t Miss Out on the AI Gold Rush That’s Just Getting StartedBanyan Hill PublishingMan Who Predicted 2008: “This Will be Worse.”AltimetryBiden out June 13; Kamala won’t replace him?Paradigm PressThe Greatest Bull Market in Crypto History…Weiss Ratings Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding aTyr Pharma, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
